Brazilian Position Statement for Familial Chylomicronemia Syndrome-2023

被引：0

作者：

de Oliveira Izar, Maria Cristina ^{[1
]}

dos Santos Filho, Raul Dias ^{[2
]}

Vieira Assad, Marcelo Heitor ^{[3
]}

Palandri Chagas, Antonio Carlos ^{[4
]}

Toledo Junior, Alceu de Oliveira ^{[5
]}

Cavalcante Nogueira, Ana Claudia ^{[6
]}

Carneiro Fernandes Souto, Ana Cristina ^{[7
]}

Pitta Lottenberg, Ana Maria ^{[8
,9
]}

Marte Chacra, Ana Paula ^{[7
]}

dos Santos Ferreira, Carlos Eduardo ^{[9
]}

Lourenco, Charles Marques ^{[10
]}

Valerio, Cynthia Melissa ^{[11
]}

Cintra, Dennys Esper ^{[12
]}

Helfenstein Fonseca, Francisco Antonio ^{[1
]}

Campana, Gustavo Aguiar ^{[13
]}

Bianco, Henrique Tria ^{[1
]}

de Lima, Josivan Gomes ^{[14
]}

Costa Gurgel Castelo, Maria Helane ^{[15
]}

Scartezini, Marileia ^{[16
]}

Moretti, Miguel Antonio ^{[7
]}

Fraife Barreto, Natasha Slhessarenko ^{[15
,17
]}

Maia, Rayana Elias ^{[18
]}

Montenegro Junior, Renan Magalhaes ^{[19
]}

Alves, Renato Jorge ^{[20
]}

Machado Figueiredo, Roberta Marcondes ^{[9
,21
]}

Fock, Rodrigo Ambrosio ^{[1
]}

da Rocha Martinez, Tania Leme ^{[22
]}

机构：

[1] Univ Fed Sao Paulo UNIFESP, Sao Paulo, SP, Brazil

[2] Univ Sao Paulo, Sao Paulo, SP, Brazil

[3] Inst Nacl Cardiol INC, Rio De Janeiro, RJ, Brazil

[4] Fac Med ABC, Sao Caetano do Sul, SP, Brazil

[5] Univ Estadual Ponta Grossa UEPG, Ponta Grossa, PR, Brazil

[6] Hosp Base Dist Fed, Brasilia, DF, Brazil

[7] Univ Sao Paulo HCFMUSP, Inst Coracao Incor, Hosp Clin, Fac Med, Sao Paulo, SP, Brazil

[8] Univ Sao Paulo HCFMUSP, Fac Med, Hosp Clin, Lab Lipides LIM 10, Sao Paulo, SP, Brazil

[9] Hosp Israelita Albert Einstein HIAE, Sao Paulo, SP, Brazil

[10] Fac Med Sao Jose Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil

[11] Inst Estadual Diabet & Endocrinol Luiz Caprigl IE, Rio De Janeiro, RJ, Brazil

[12] Estadual Campinas UNICAMP, Campinas, SP, Brazil

[13] Alliar Medicina Diagnost, Sao Paulo, SP, Brazil

[14] Univ Fed Rio Grande Norte UFRN, Hosp Univ Onofre Lopes, Natal, RN, Brazil

[15] Diagnost Amer SA DASA, Fortaleza, CE, Brazil

[16] Univ Fed Parana UFPR, Curitiba, PR, Brazil

[17] Univ Fed Mato Grosso UFMT, Cuiaba, MT, Brazil

[18] Univ Fed Paraiba UFPB, Joao Pessoa, PB, Brazil

[19] Empresa Brasileira Serv Hosp EBSERH, Complexo Hosp Univ Fed Ceara UFCE, Fortaleza, CE, Brazil

[20] Hosp St Casa Misericordia Sao Paulo, Sao Paulo, SP, Brazil

[21] Fac Israelita Ciencias Saude Albert Einstein FICS, Sao Paulo, SP, Brazil

[22] Hosp Beneficencia Portuguesa Sao Paulo, Sao Paulo, SP, Brazil

来源：

ARQUIVOS BRASILEIROS DE CARDIOLOGIA | 2023年 / 120卷 / 04期

关键词：

THERAPEUTIC PLASMA-EXCHANGE; LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN C-III; HYPERTRIGLYCERIDEMIA-INDUCED PANCREATITIS; MEDIUM-CHAIN TRIGLYCERIDES; DE-NOVO LIPOGENESIS; FATTY-ACIDS; HYPERLIPIDEMIC PANCREATITIS; CLINICAL CHARACTERISTICS; SCIENTIFIC STATEMENT;

D O I：

10.36660/abc.20230203

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

(iii) any legal person in which any of these is either a direct or indirect controlling owner, business partner, shareholder or advisory boards, investigative boards or other committees, etc. From the brazilian or international pharmaceutical, orthosis, Funding of continuing medical education activities, including travel, accommodation and registration in conferences and Any economically relevant equity interest in companies in the healthcare or education industry or in any companies competing

引用

下载

页数：39

共 50 条

[31] Familial chylomicronemia syndrome in children: a diagnosis challenge
Ariza, Maria Jose
Valdivielso, Pedro
TRANSLATIONAL PEDIATRICS, 2022, 11 (11) : 1743 - 1747
[32] Effectiveness and safety of lomitapide in a patient with familial chylomicronemia syndrome
Cefalu, Angelo B.
Giammanco, Antonina
Noto, Davide
Spina, Rossella
Cabibi, Daniela
Barbagallo, Carlo M.
Averna, Maurizio
ENDOCRINE, 2021, 71 (02) : 344 - 350
[33] Pregnancy in Familial Chylomicronemia syndrome: Plasmapheresis as Therapeutic Approach
Dunja, Leskovar
Marina, Sabic
Drazen, Perica
Nediljko, Sucur
Ana, Godan Hauptman
Iveta, Mercep
Fran, Borovecki
Bojan, Jelakovic
Zeljko, Reiner
Ivan, Pecin
METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 116 : 22 - 22
[34] FAMILIAL CHYLOMICRONEMIA SYNDROME: DESCRIPTION OF A FRENCH CANADIAN COHORT
Baass, Alexis
Paquette, Martine
Dufour, Robert
ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 15 - 15
[35] Targeting APOC3 in the Familial Chylomicronemia Syndrome
Gaudet, Daniel
Brisson, Diane
Tremblay, Karine
Alexander, Veronica J.
Singleton, Walter
Hughes, Steven G.
Geary, Richard S.
Baker, Brenda F.
Graham, Mark J.
Crooke, Rosanne M.
Witztum, Joseph L.
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (23): : 2200 - 2206
[36] EFFECTIVENESS AND SAFETY OF LOMITAPIDE IN A PATIENT WITH FAMILIAL CHYLOMICRONEMIA SYNDROME
Giammanco, A.
Cefalu, A. B.
Noto, D.
Spina, R.
Cabibi, D.
Barbagallo, C. M.
Averna, M.
ATHEROSCLEROSIS, 2021, 331 : E181 - E181
[37] Roundtable discussion: Familial chylomicronemia syndrome: Diagnosis and management
Brown, William Virgil
Goldberg, Ira
Duell, Barton
Gaudet, Daniel
JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (02) : 254 - 263
[38] Editorial commentary: Dietary management of familial chylomicronemia syndrome
Williams, Lauren
Wilson, Don P.
JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (03) : 462 - 465
[39] Effectiveness and safety of lomitapide in a patient with familial chylomicronemia syndrome
Angelo B. Cefalù
Antonina Giammanco
Davide Noto
Rossella Spina
Daniela Cabibi
Carlo M. Barbagallo
Maurizio Averna
Endocrine, 2021, 71 : 344 - 350
[40] Prevalence of familial chylomicronemia syndrome in a quaternary care center
Pallazola, Vincent A.
Sajja, Aparna
Derenbecker, Robert
Ogunmoroti, Oluseye
Park, Jihwan
Sathiyakumar, Vasanth
Martin, Seth S.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (19) : 2276 - 2278

← 1 2 3 4 5 →